Chronic disease costs from a patient’s perspective: A survey of patients with stroke, heart disease, and chronic kidney disease visiting a district hospital in Indonesia

Context: Chronic disease treatment can lead to catastrophic costs. Although most direct medical costs are covered by the National Health Insurance, direct nonmedical and indirect costs may be burdensome for patients. Aims: To estimate the cost of chronic diseases from a patient’s perspective. Methods: A total of 315 patients with stroke (n = 105), heart disease (n = 108), and chronic kidney disease (n = 102) visiting a district hospital in Yogyakarta Province in Indonesia were included in this study. Data were collected through interviews and analyzed using descriptive statistics. Significant differences in mean costs between different groups seeking healthcare facilities were determined using the Mann–Whitney U test. Results: The estimated total out-of-pocket (OOP) costs per patient within three months were IDR 3,411,662 (USD 227.4), IDR 632,665 (USD 42.2), and IDR 3,227,951 (USD 215.2) for stroke, heart disease, and chronic kidney disease, respectively. OOP costs for the three diseases accounted for 9–49% of minimum regional wages. Indirect costs were the highest costs contributing to the total OOP cost (33–64%), followed by direct medical costs (12–57%) and direct nonmedical costs (5–33%). Patients seeking additional treatment at other healthcare facilities tended to have significantly higher costs. Conclusions: This study showed that chronic diseases put a relatively high economic burden on patients. Additionally, seeking more healthcare facilities tends to increase costs.

Authors

Publication Details

Journal
Journal of Pharmacy & Pharmacognosy Research
Published
2024-09-10
DOI
https://doi.org/10.56499/jppres24.2036_13.1.274
Citations
4
Primary Topic
Health Systems, Economic Evaluations, Quality of Life
Type
article
Field-Weighted Citation Impact
4.52
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Chronic disease costs from a patient’s perspective: A survey of patients with stroke, heart disease, and chronic kidney disease visiting a district hospital in Indonesia

Dwi Endarti, Tri Murti Andayani, Anna Wahyuni Widayanti, Syifaur Rohmah et al.
4 citations
Journal of Pharmacy & Pharmacognosy Research
Health Systems, Economic Evaluations, Quality of Life
4.52
article

Chronic disease costs from a patient’s perspective: A survey of patients with stroke, heart disease, and chronic kidney disease visiting a district hospital in Indonesia

Dwi Endarti, Tri Murti Andayani, Anna Wahyuni Widayanti, Syifaur Rohmah, Nurul Adzkia Ghearizky, Resi Rizki Banjarani
article en
4 citations

Abstract

Context: Chronic disease treatment can lead to catastrophic costs. Although most direct medical costs are covered by the National Health Insurance, direct nonmedical and indirect costs may be burdensome for patients. Aims: To estimate the cost of chronic diseases from a patient’s perspective. Methods: A total of 315 patients with stroke (n = 105), heart disease (n = 108), and chronic kidney disease (n = 102) visiting a district hospital in Yogyakarta Province in Indonesia were included in this study. Data were collected through interviews and analyzed using descriptive statistics. Significant differences in mean costs between different groups seeking healthcare facilities were determined using the Mann–Whitney U test. Results: The estimated total out-of-pocket (OOP) costs per patient within three months were IDR 3,411,662 (USD 227.4), IDR 632,665 (USD 42.2), and IDR 3,227,951 (USD 215.2) for stroke, heart disease, and chronic kidney disease, respectively. OOP costs for the three diseases accounted for 9–49% of minimum regional wages. Indirect costs were the highest costs contributing to the total OOP cost (33–64%), followed by direct medical costs (12–57%) and direct nonmedical costs (5–33%). Patients seeking additional treatment at other healthcare facilities tended to have significantly higher costs. Conclusions: This study showed that chronic diseases put a relatively high economic burden on patients. Additionally, seeking more healthcare facilities tends to increase costs.

Journal of Pharmacy & Pharmacognosy ResearchVol. 13(1)
Openalex Percentile: Top 5%
Health Systems, Economic Evaluations, Quality of Life
4.52
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Chronic disease costs from a patient’s perspective: A survey of patients with stroke, heart disease, and chronic kidney disease visiting a district hospital in Indonesia — Dwi Endarti, Tri Murti Andayani, et al. · Journal of Pharmacy & Pharmacognosy Research (2024) | TGRS Research Map | TGRS